Your browser is no longer supported. Please, upgrade your browser.
Settings
CERU Cerulean Pharma Inc. daily Stock Chart
CERU [NASD]
Cerulean Pharma Inc.
Index- P/E- EPS (ttm)-1.43 Insider Own1.30% Shs Outstand29.54M Perf Week-8.09%
Market Cap19.14M Forward P/E- EPS next Y-0.62 Insider Trans0.00% Shs Float28.48M Perf Month-12.43%
Income-39.30M PEG- EPS next Q-0.31 Inst Own38.70% Short Float8.15% Perf Quarter-15.60%
Sales0.80M P/S23.93 EPS this Y8.90% Inst Trans0.16% Short Ratio0.56 Perf Half Y-29.19%
Book/sh0.46 P/B1.41 EPS next Y58.10% ROA-82.40% Target Price3.75 Perf Year-83.68%
Cash/sh1.18 P/C0.55 EPS next 5Y- ROE-171.70% 52W Range0.63 - 4.15 Perf YTD-8.50%
Dividend- P/FCF- EPS past 5Y-0.70% ROI-143.50% 52W High-84.39% Beta-
Dividend %- Quick Ratio2.20 Sales past 5Y20.20% Gross Margin- 52W Low2.81% ATR0.19
Employees19 Current Ratio2.20 Sales Q/Q- Oper. Margin- RSI (14)40.26 Volatility3.99% 10.28%
OptionableYes Debt/Eq0.98 EPS Q/Q56.00% Profit Margin- Rel Volume0.08 Prev Close0.64
ShortableYes LT Debt/Eq0.34 EarningsMar 31 AMC Payout- Avg Volume4.15M Price0.65
Recom2.00 SMA20-8.40% SMA50-47.04% SMA200-47.51% Volume351,529 Change0.78%
Aug-30-16Reiterated Barclays Overweight $5 → $2
Aug-18-16Downgrade Leerink Partners Outperform → Mkt Perform
Aug-18-16Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-22-15Initiated Barclays Overweight $8
Aug-28-15Initiated ROTH Capital Buy $9
May-06-14Initiated Canaccord Genuity Buy $11
Mar-31-17 04:09PM  CERULEAN PHARMA INC. Files SEC form 10-K, Annual Report
Mar-24-17 11:46AM  CERULEAN PHARMA INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Mar-21-17 04:20PM  CERULEAN PHARMA INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
03:00PM  As Cerulean Pharma winds down, executives get a parting gift: bonuses at bizjournals.com
Mar-20-17 09:38PM  Cerulean and Daré to Host Conference Call on Proposed Transaction on March 23 Business Wire -62.35%
10:15AM  Waltham's Cerulean Pharma to cut staff, merge with San Diego biotech at bizjournals.com
08:09AM  CERULEAN PHARMA INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Defini
08:00AM  Cerulean Pharma and Daré Bioscience Enter into Stock Purchase Agreement Business Wire
Mar-15-17 10:38AM  Stick to Small, Fast Trades Until the Fed's out of the Way +33.04%
Mar-14-17 09:30AM  Cerulean Pharma Attracts Investors and Possible Suitor, Protalix Returns to the Spotlight Accesswire -10.04%
Feb-01-17 11:20AM  Waltham-based cancer drug firm Cerulean Pharma may seek a buyer at bizjournals.com
08:00AM  Cerulean Announces Review of Strategic Alternatives Business Wire
Jan-09-17 08:42AM  3 Reasons Why Cerulean Pharma (CERU) is a Great Momentum Stock
Dec-04-16 04:40PM  5 Stocks Poised for Major Breakouts--Gold, Pharma and Tech at TheStreet
Nov-18-16 08:02AM  CERULEAN PHARMA INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa
Nov-15-16 01:04PM  CERULEAN PHARMA INC. Financials
Nov-08-16 04:43PM  CERULEAN PHARMA INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Nov-04-16 05:03AM  Cerulean reports 3Q loss
01:36AM  Edited Transcript of CERU earnings conference call or presentation 3-Nov-16 8:30pm GMT
Nov-03-16 04:26PM  CERULEAN PHARMA INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi -6.20%
04:11PM  CERULEAN PHARMA INC. Files SEC form 10-Q, Quarterly Report
04:11PM  Cerulean Reports Third Quarter 2016 Financial Results and Provides Corporate Update Business Wire
07:07AM  Q3 2016 Cerulean Pharma Inc Earnings Release - After Market Close
Oct-27-16 07:00AM  Cerulean to Host Third Quarter 2016 Conference Call on November 3 Business Wire
Oct-26-16 07:00AM  Cerulean Announces Promotion of Scott Eliasof, PhD to Senior Vice President and Chief Scientific Officer Business Wire
Oct-19-16 08:07AM  CERULEAN PHARMA INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statemen +39.54%
08:01AM  Cerulean Announces Technology Platform Collaboration Business Wire
08:00AM  Cerulean Announces $20 Million Firm Commitment At-The-Market Stock Purchase Agreement with Aspire Capital Fund, LLC Business Wire
Oct-18-16 05:07PM  CERULEAN PHARMA INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit
Oct-06-16 07:00AM  Cerulean Announces Data Presentations at the 2016 European Society for Medical Oncology Annual Meeting Business Wire
Oct-04-16 09:15AM  Key FDA Decisions and Trial Results Expected in October at 24/7 Wall St.
Sep-08-16 08:05AM  Key FDA Decisions and Trial Results Expected in October at 24/7 Wall St.
Aug-30-16 02:19PM  Barclays Remains Positive On Cerulean Pharma Despite Failed Renal Cancer Trial
Aug-21-16 10:05AM  6 Companies That Destroyed Shareholders Last Week at 24/7 Wall St.
Aug-19-16 01:49PM  Cerulean Pharma Inc (CERU): Whats Next? at Insider Monkey
Aug-18-16 04:08PM  CERULEAN PHARMA INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -56.20%
04:01PM  Cerulean Announces Reduction in Force Business Wire
11:50AM  Thursdays Top Health Care Stocks Punishing Investors at 24/7 Wall St.
11:32AM  Cerulean Pharma (CERU) Stock Tumbles on Lead Kidney Cancer Drug Failure
10:11AM  Cerulean (CERU) Kidney Cancer Drug Disappoints in Phase II
07:13AM  Cerulean Pharma downgraded by Leerink Partners and JMP Securities
Aug-17-16 04:09PM  CERULEAN PHARMA INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:01PM  Cerulean Announces Results from Phase 2 Clinical Trial of CRLX101 and Avastin® Combination in Relapsed Renal Cell Carcinoma Business Wire
Aug-05-16 02:08PM  Edited Transcript of CERU earnings conference call or presentation 4-Aug-16 8:30pm GMT
Aug-04-16 05:51PM  Cerulean reports 2Q loss
04:18PM  CERULEAN PHARMA INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:05PM  Cerulean Reports Second Quarter 2016 Corporate Highlights and Financial Results Business Wire
04:04PM  CERULEAN PHARMA INC. Files SEC form 10-Q, Quarterly Report
07:07AM  Q2 2016 Cerulean Pharma Inc Earnings Release - Time Not Supplied
Jul-28-16 07:00AM  Cerulean to Host Second Quarter 2016 Conference Call on August 4 Business Wire
Jul-19-16 06:56PM  Why Did Cerulean Pharmaceuticals (CERU) Surge 30% Today? +29.82%
12:45PM  Why These Stocks Are Gaining Ground on Tuesday? at Insider Monkey
07:30AM  Cerulean Receives FDA Fast Track Designation for CRLX101 for the Treatment of Platinum-Resistant Ovarian Cancer Business Wire
Jul-18-16 08:45AM  Cerulean Pharma (CERU) Worth a Look: Stock Gains 9.1%
Jun-27-16 04:17PM  CERULEAN PHARMA INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-23-16 07:00AM  Cerulean Announces First Patient Dosed in Phase 2a Expansion Stage Evaluating CRLX301 in Patients with Advanced Solid Tumors Business Wire
Jun-22-16 09:20AM  Cerulean Announces Publication in Cancer Research Business Wire
Jun-14-16 07:00AM  Cerulean to Present at JMP Securities Life Sciences Conference Business Wire
Jun-10-16 05:03PM  Cerulean Pharma, Inc. :CERU-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016
Jun-09-16 07:00AM  Cerulean Announces Manuscript Published in Annals of Oncology Business Wire
May-27-16 04:27PM  CERULEAN PHARMA INC. Files SEC form 8-K, Change in Directors or Principal Officers
May-19-16 07:00AM  Cerulean Announces Oral Presentation of CRLX101 Clinical Data at Gynecologic Oncology 2016 Conference Business Wire
May-18-16 05:12PM  Cerulean to Present at the 2016 ASCO Annual Meeting Business Wire
May-10-16 07:30AM  Cerulean Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRLX101 in Combination with LYNPARZA Business Wire
May-02-16 11:13PM  Edited Transcript of CERU earnings conference call or presentation 2-May-16 8:30pm GMT -5.49%
05:31PM  Cerulean reports 1Q loss
04:14PM  CERULEAN PHARMA INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:06PM  Cerulean Reports First Quarter 2016 Corporate Highlights and Financial Results Business Wire
04:04PM  CERULEAN PHARMA INC. Files SEC form 10-Q, Quarterly Report
07:07AM  Q1 2016 Cerulean Pharma Inc Earnings Release - Time Not Supplied CCBN
Apr-25-16 09:00AM  Cerulean Announces Oral Presentation of CRLX101 Clinical Data at Gynecologic Oncology 2016 Conference Business Wire
07:00AM  Cerulean to Host First Quarter 2016 Conference Call on May 2 Business Wire
Apr-20-16 11:04AM  Waltham's Cerulean gains on promising trial news from ovarian cancer drug at American City Business Journals +9.97%
Apr-19-16 07:00AM  Cerulean Announces Presentation at 2016 American Association for Cancer Research Annual Meeting of Stage 1 Data from Phase 2 Trial in Platinum-Resistant Ovarian Cancer Business Wire +9.06%
Apr-07-16 09:30AM  Biotech Volatility Both Good And Bad Accesswire
Apr-05-16 07:00AM  Cerulean to Present at 15th Annual Needham Healthcare Conference Business Wire
Apr-04-16 08:15AM  Cerulean Pharma (CERU) Jumps: Stock Moves 8.5% Higher
Mar-28-16 08:02AM  Analyst Report; Expected FDA Decisions Around the Corner Accesswire -5.51%
Mar-23-16 02:17PM  Office Depot (ODP), Valeant (VRX) Among 5 of the Days Big Winners at Insider Monkey +11.90%
01:24PM  Top Penny Stocks On Wednesday March 23, 2016 Accesswire
12:20PM  Here's Why Cerulean Pharma (CERU) Stock is Spiking Today at TheStreet
07:09AM  Cerulean Announces Publication Showing CRLX101 Localizes Selectively in Human Tumors, Sparing Adjacent Healthy Tissue at noodls
07:00AM  Cerulean Announces Publication Showing CRLX101 Localizes Selectively in Human Tumors, Sparing Adjacent Healthy Tissue Business Wire
Mar-21-16 07:17AM  Cerulean Presents CRLX301 Phase 1 Data at the 14th International Congress on Targeted Anticancer Therapies at noodls
07:00AM  Cerulean Presents CRLX301 Phase 1 Data at the 14th International Congress on Targeted Anticancer Therapies Business Wire
Mar-16-16 04:37PM  Cerulean Announces Data Presentations at the 2016 American Association for Cancer Research Annual Meeting Business Wire
Mar-11-16 12:58AM  Edited Transcript of CERU earnings conference call or presentation 10-Mar-16 9:30pm GMT
Mar-10-16 06:19PM  Cerulean reports 4Q loss
04:30PM  Cerulean Pharma Inc Earnings Call scheduled for 4:30 pm ET today
04:17PM  CERULEAN PHARMA INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:07PM  Cerulean Reports Fourth Quarter 2015 Corporate Highlights and Financial Results Business Wire
04:06PM  CERULEAN PHARMA INC. Files SEC form 10-K, Annual Report
07:07AM  Q4 2015 Cerulean Pharma Inc Earnings Release - After Market Close
Mar-07-16 07:00AM  Cerulean to Present at Two Upcoming March Conferences
Mar-03-16 07:00AM  Cerulean to Host Fourth Quarter 2015 Conference Call on March 10 Business Wire +16.34%
Feb-01-16 07:30AM  Cerulean to Present at Two Upcoming Conferences at noodls
07:00AM  Cerulean to Present at Two Upcoming Conferences
Dec-21-15 07:00AM  Cerulean Announces Relocation to New Office and Laboratory Space in Waltham, Massachusetts Business Wire
Dec-04-15 08:15AM  Cerulean Pharma (CERU) Jumps: Stock Adds 6.1% in Session
Dec-02-15 08:25AM  Equities Driven By Market Influences - Research on Huttig Building Products, Pain Therapeutics, Dixie Group and Cerulean Pharma Accesswire +5.47%
Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The company's lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301, a platform-generated NDC clinical candidate, which is in Phase 1/2a clinical trials. The company has a strategic collaboration with Novartis to develop nanoparticle-drug conjugates for various cancer tumor targets. The company was formerly known as Tempo Pharmaceuticals, Inc. and changed its name to Cerulean Pharma Inc. in October 2008. Cerulean Pharma Inc. was incorporated in 2005 and is based in Waltham, Massachusetts.